NCT03603821

Brief Summary

Descriptive prospective study carried out to compare the results obtained by self-administered IPSS (International Prostate Symptom Score), Sanitary staff-supervised IPSS and directed medical interview and its correlation with clinical parameters in the assessment of lower urinary tract symptoms in males.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 24, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 27, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

July 30, 2018

Status Verified

July 1, 2018

Enrollment Period

2.2 years

First QC Date

July 16, 2018

Last Update Submit

July 27, 2018

Conditions

Keywords

LUTSQUESTIONNAIREIPSS

Outcome Measures

Primary Outcomes (1)

  • correlation between different clinical severity scores in LUTS

    correlation between the scores obtained with an self-administered IPSS, a sanitary staff-supervised IPSS and a standard medical interview focused on LUTS based on a Likert severity scale 0-4 (5 levels of severity)

    data will be measured once all questionnaires are provided and objective explorations performed. All data will be obtained in a maximum of 30 days period for each patient. During this period of time the patient will not change any of his treatments.

Secondary Outcomes (1)

  • correlation between clinical severity scores and objective severity symptoms

    data will be measured once all questionnaires are provided and objective explorations performed. All data will be obtained in a maximum of 30 days period for each patient. During this period of time the patient will not change any of his treatments.

Study Arms (1)

LUTS male

Clinical assesment of males older than 50 years with lower urinary tract symptoms presumably related to benign prostate enlargement

Diagnostic Test: CLINICAL ASSESMENT

Interventions

CLINICAL ASSESMENTDIAGNOSTIC_TEST

IPSS questionnaire, uroflowmetry, prostate and bladder ultrasonography, voiding diary, medical interview

Also known as: Ultrasonography, IPSS questionnaire, Voiding diary, Uroflowmetry
LUTS male

Eligibility Criteria

Age50 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Males older than 50 years with low urinary symptoms followed in the investigator's Urology outpatient clinic

You may qualify if:

  • males older than 50 years, with LUTS

You may not qualify if:

  • Urinary tract infection
  • Bladder tumor o lithiasis
  • changes in LUTS treatment during the analysis period (pharmacological or surgical)
  • urethral manipulation during the analysis period (catheterization or cystoscopy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Corporacion Sanitaria Parc Tauli

Sabadell, Barcelona, 08208, Spain

RECRUITING

MeSH Terms

Conditions

Lower Urinary Tract Symptoms

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Urological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • EDUARDO VICENTE PALACIO, UROLOGIST

    CORPORATION PARC TAULI

    STUDY DIRECTOR

Central Study Contacts

EDUARDO VICENTE PALACIO, UROLOGIST

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior and Consultor Staff in the Department of Urology

Study Record Dates

First Submitted

July 16, 2018

First Posted

July 27, 2018

Study Start

May 24, 2017

Primary Completion

August 1, 2019

Study Completion

December 1, 2019

Last Updated

July 30, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will share

Locations